The levels of ESR2 RNA were reduced in adrenocortical carcinoma (ACC), ovarian cancer (OV), pheochromocytoma and paraganglioma (PCPG), and testicular germ cell tumors (TGCTs). Here, ESR2 is linked to ovarian cancer.